Back
Tema Oncology ETF Vs. Belite Bio Industry Stock Comparison
Buy
57
CANC
Tema Oncology ETF
Last Price:
26.90
Seasonality Move:
21.07%
Buy
89
BLTE
Belite Bio
Last Price:
67.60
Seasonality Move:
11.16%
Buy
57
Tema Oncology ETF (CANC)
is a Buy
Is Tema Oncology ETF a Buy, Sell or Hold?
- The current Tema Oncology ETF [CANC] share price is $27.69. The Score for CANC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- CANC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
89
Belite Bio (BLTE)
is a Buy
Is Belite Bio a Buy, Sell or Hold?
- The current Belite Bio [BLTE] share price is $67.44. The Score for BLTE is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- BLTE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CANC Stock Price Chart
What is Tema Oncology ETF's stock price today?
-
The Tema Oncology ETF share price today is $27.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANC is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $67.44
The current trend is moderately bearish and BLTE is experiencing slight buying pressure.
CANC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 52.48 | Buy |
| Chaikin Money Flow: | 1750 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.74 - 28.34) | Buy |
| Bollinger Bands (100): | (27.56 - 29.36) | Sell |
BLTE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.5 | Buy |
| Relative Strength Index (14 RSI): | 42.18 | Sell |
| Chaikin Money Flow: | 27107 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.71 - 82.51) | Sell |
| Bollinger Bands (100): | (44.39 - 68.09) | Buy |
CANC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.76 | Buy |
| 20-day SMA: | 27.49 | Buy |
| 50-day SMA: | 27.93 | Sell |
| 200-day SMA: | 27.86 | Sell |
| 8-day EMA: | 27.15 | Buy |
| 20-day EMA: | 27.36 | Buy |
| 50-day EMA: | 27.81 | Sell |
| 200-day EMA: | 27.41 | Buy |
BLTE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.14 | Sell |
| 20-day SMA: | 77.31 | Sell |
| 50-day SMA: | 63.62 | Buy |
| 200-day SMA: | 50.02 | Buy |
| 8-day EMA: | 74.43 | Sell |
| 20-day EMA: | 74.55 | Sell |
| 50-day EMA: | 66.97 | Buy |
| 200-day EMA: | 52.46 | Buy |
Tema Oncology ETF Earnings Growth & CANC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Tema Oncology ETF Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Belite Bio Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||